60 likes | 144 Views
Otitis Media - Pipeline Review, H2 2015 is now available at RnRMarketResearch.com This report provides an overview of the Otitis Media's therapeutic pipeline.
E N D
Otitis Media - Pipeline Review, H2 2015 By RnRMarketResearch Browse more reports on Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/ent-therapeutics . This is a premium report price at US$2000 for a single user PDF license ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Otitis Media - Pipeline Review, H2 2015 Otitis Media - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Otitis Media, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Otitis Media and special features on late-stage and discontinued projects. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Otitis Media - Pipeline Review, H2 2015 Scope: • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • A review of the Otitis Media products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • A detailed assessment of monotherapy and combination therapy pipeline projects • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Otitis Media - Pipeline Review, H2 2015 Reasons to buy: • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Otitis Media • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Otitis Media pipeline depth and focus of Indication therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Otitis Media - Pipeline Review, H2 2015 Table of Contents: Otitis Media - Products under Development by Companies Otitis Media - Products under Investigation by Universities/Institutes Otitis Media - Companies Involved in Therapeutics Development Cellceutix Corporation ContraFect Corporation GlaxoSmithKline Plc Laboratorios SALVAT S.A. Merck & Co., Inc. MerLion Pharmaceuticals Pte Ltd Oticpharma Ltd ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Otitis Media - Pipeline Review, H2 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441